Ivermectin

Scabies and impetigo prevalence was reduced significantly with mass administration of ivermectin or permethrin in small Indian communities, according to a study.

Moxidectin was noninferior to ivermectin for patients with strongyloidiasis, according to data published in The Lancet Infectious Diseases.

MIAMI BEACH, Fla. — Rosacea is often a combination disease requiring combination therapies, according to a speaker here.

Last week, the FDA authorized a second COVID-19 booster dose for people aged 50 years or older and certain immunocompromised individuals.

Ivermectin did not lower the incidence of hospitalization among high-risk adults with COVID-19 enrolled in a large double-blind, randomized, placebo-controlled trial in Brazil, researchers reported in The New England Journal of Medicine.

Home testing for COVID-19 is a crucial part of keeping safe this holiday season, according to William Schaffner, MD, and Amesh A. Adalja, MD. A review of proper COVID-19 precautions was the top story in infectious disease last week.

Although not recommended to treat COVID-19, ivermectin has shown the potential to stop the spread of some infectious diseases, according to several studies presented at the American Society of Tropical Medicine and Hygiene Annual Meeting.

Several medical organizations said they were vehemently “against the ordering, prescribing or dispensing of ivermectin to prevent or treat COVID-19” when it is not being used in a clinical trial.

Experts said that ivermectin has demonstrated in vitro activity against SARS-CoV-2, but due to the lack of clinical data, they are skeptical of its potential as a COVID-19 therapy.

The FDA is clear about the use of ivermectin, a drug used primarily to treat intestinal strongyloidiasis and onchocerciasis, as a potential therapy for COVID-19: It is not approved.